Valuation: Celltrion, Inc.

Market Cap 44,408B 33.52B 29.93B 27.65B 25.06B 46.88B 3,182B 47.66B 333B 132B 1,667B 126B 123B 5,256B P/E 2026 *
28.9x
P/E 2027 * 25.3x
Enterprise Value 46.05B 34.76M 31.04M 28.67M 25.99M 48.62M 3.3B 49.42M 345M 137M 1.73B 130M 128M 5.45B EV / Sales 2026 *
8.21x
EV / Sales 2027 * 7.15x
Free-Float
58.02%
Yield 2026 *
0.37%
Yield 2027 * 0.4%
1 day+0.05%
1 week+0.21%
Current month+9.40%
1 month+9.58%
3 months+9.46%
6 months-2.33%
Current year+12.77%
1 week 189,500
Extreme 189500
203,500
1 month 173,700
Extreme 173700
203,500
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 128,553.99
Extreme 128553.985695
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 19/03/2015
Chief Executive Officer 42 25/03/2021
President 51 12/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 31/03/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/01/26 Sell 500 0.0002%
16/01/26 Sell 1,000 0.0004%
16/01/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+0.21%+18.06%+48.50% 33.52B
+2.41%+0.29%+39.41%+72.14% 64.69B
-0.15%+7.50%+11.42%+71.27% 54.78B
+0.57%+4.60%+7.71%+90.93% 53.49B
+0.37%+4.67%+26.68%+49.64% 45.98B
-1.21%+2.32%+21.50%+118.33% 42.94B
-0.37%+5.07%+243.23%+789.58% 40.08B
+1.19%-4.98%+26.31%-0.76% 23.97B
-0.38%+5.68%+38.39%+28.35% 23.67B
-1.73%+0.46%-16.61%-8.02% 22.13B
Average +0.08%+2.22%+41.61%+126.00% 40.52B
Weighted average by Cap. +0.27%+2.61%+42.60%+134.60%

Financials

2026 *2027 *
Net sales 5,606B 4.23B 3.78B 3.49B 3.16B 5.92B 402B 6.02B 42.01B 16.63B 210B 15.88B 15.54B 664B 6,389B 4.82B 4.31B 3.98B 3.61B 6.75B 458B 6.86B 47.88B 18.95B 240B 18.1B 17.71B 756B
Net income 1,590B 1.2B 1.07B 990M 897M 1.68B 114B 1.71B 11.92B 4.72B 59.71B 4.51B 4.41B 188B 1,777B 1.34B 1.2B 1.11B 1B 1.88B 127B 1.91B 13.32B 5.27B 66.73B 5.04B 4.93B 210B
Net Debt 1,639B 1.24B 1.11B 1.02B 925M 1.73B 117B 1.76B 12.29B 4.86B 61.55B 4.64B 4.55B 194B 1,273B 961M 858M 793M 718M 1.34B 91.21B 1.37B 9.54B 3.78B 47.79B 3.61B 3.53B 151B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
23/10/26 ₩194,400.00 +0.05% 454,998
22/10/26 ₩194,300.00 -1.67% 520,793
21/10/26 ₩197,600.00 +0.10% 601,867
20/10/26 ₩197,400.00 -0.40% 705,641
19/10/26 ₩198,200.00 +2.16% 701,654
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
194,400.00KRW
Average target price
269,303.03KRW
Spread / Average Target
+38.53%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celltrion, Inc.
  1. Stock Market
  2. Stocks
  3. A068270 Stock